ABOUT
Our Members
Board of Directors
Staff
Our Support
Contact Us
Issue Areas
COVID-19
Health Equity, Diversity, & Inclusion
Reducing Health Costs
Health Care Reform
Value
Real-World Evidence
Patient Engagement
FDA Regulations
Resources
Member Resources
Fair-Market Value Calculator
Meetings & Events
Newsroom
Letters & Comments
Job Bank
Education
Health Care Quality
Value Classroom
Real-World Evidence Classroom
Patient-Focused Medical Product Development Series
Webinars
Blog
Membership
Our Members
Standards of Excellence
Join Us
Toggle navigation
letters & comments
Advance Notice of Proposed Rulemaking: International Price Index Model for Medicare Part B Drugs
12/31/2018
Read More
Centers for Medicare & Medicaid Services’ (CMS’) State Relief and Empowerment Waivers
12/24/2018
Read More
Patient-Focused Drug Development Guidance: Methods To Identify What Is Important to Patients and Select, Develop, or Modify Fit-for-Purpose Clinical Outcome Assessments
12/14/2018
Read More
CMS’s Accountable Care Organizations Pathways to Success
10/16/2018
Read More
FDA Standard Core Clinical Outcome Assessments and Endpoints
10/15/2018
Read More
Letter to Secretary Azar on the Administration’s Step Therapy Policy
09/26/2018
Read More
Proposed Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs
09/26/2018
Read More
FDA’s Draft Guidance on Patient-Focused Drug Development: Collecting Comprehensive and Representative Input
09/11/2018
Read More
Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs
07/16/2018
Read More
« Previous
1
2
3
4
5
6
7
8
Next »